Written for executives and administrators in the pharmaceutical and biotechnology industries. Highlights all aspects of the pharmaceutical industry, including marketing, research and development and regulatory and legislative issues. Regular features include regulatory news, drug approvals, FDA advisory committee meetings, enforcement reports, business and marketing news, financial news and managed care developments.

Aimed a senior pharmaceutical industry executives, project managers and other business decision makers at pharmaceutical and related life sciences companies, FiercePharma provides daily insider news from the post-approval world including manufacturing, labeling, post-marketing issues and other pharmaceutical industry business topics with a special focus on pharmaceutical company news and the market development of FDA approved products. It includes additional coverage on specific topics such as the changing landscape of generic drugs, pharmaceutical sales and marketing news and manufacturing issues. FiercePharma DOES accept bylined articles/submissions. Contact the editor. The newsletter claims over 150,000 subscribers.

Scrip Pharma Intelligence is an online portal providing around-the-clock news and analysis on regulatory, legal and financial developments affecting pharmaceutical, biologics and medical device manufacturers doing business in China, India, Japan and other nations of the Pacific Rim. The editorial team of Scrip Pharma Intelligence has access to a comprehensive network of insiders in industry, government and the investment community. Scrip Pharma Intelligence aims to provide highly specialized industry insight on the Asian marketplace, plus editor's picks from the world press and English summaries of Chinese and Japanese news. PharmAsia News is read by Pharma, biotech and device professionals looking for high-quality coverage of business and regulatory developments in the Pacific Rim rely on PharmAsia News to help them monitor rapidly-changing events first-hand; anticipate regulatory and safety developments (Healthcare Policy); reduce the risk of corruption violations; and understand local business customs.

Established in 1977 and written for manufacturers and producers of pharmaceuticals and medical devices. Offers practical, hands-on information on all aspects of pharmaceutical research, development, manufacturing and processing including: manufacturing machinery and equipment; recipients, chemicals and raw materials; solid dosage forms; and parenterals. Regular editorial topics are: contract services, drug delivery, IT/automation/21CFR11, manufacturing equipment and supplies, packaging and labeling, FDA/regulatory and compliance, cleanrooms/aseptic processing, analysis and testing, parenterals, solid dosage forms, excipients and biopharmaceutical technology. Departments include: From the Editor, Letters, Current Technical Literature, Information Showcase, What's New, New Products, New Literature, Advertisers, Calendar, Career Opportunities and Classified Directory. Columns include Washington Report and Biotech Trends. Also publishes a Buyer's Guide in July, an Outsourcing Resources Directory in August, a IT Solutions/Automation issue in November, and a Corporate Capabilities issue in December. Accepts bylined articles.

Established in 1981 and written as a global business and marketing magazine for pharmaceutical executives. Offers coverage of the latest marketing techniques, IT for strategic and tactical use, R and D, product development, industry business trends, sales and promotional strategies, legal and regulatory changes as well as profiles of executives in the field. Pharmaceutical Executive DOES accept bylined articles/submissions from vendors. Contact Editor-in-Chief with all queries and submissions. Click here for additional guidelines and information. This outlet offers RSS (Really Simple Syndication) and Podcasts.